Outcomes of kidney transplantation in HIV-infected recipients
- PMID: 21083386
- PMCID: PMC3028983
- DOI: 10.1056/NEJMoa1001197
Outcomes of kidney transplantation in HIV-infected recipients
Erratum in
- N Engl J Med. 2011 Mar 17;364(11):1082
Abstract
Background: The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood.
Methods: We undertook a prospective, nonrandomized trial of kidney transplantation in HIV-infected candidates who had CD4+ T-cell counts of at least 200 per cubic millimeter and undetectable plasma HIV type 1 (HIV-1) RNA levels while being treated with a stable antiretroviral regimen. Post-transplantation management was provided in accordance with study protocols that defined prophylaxis against opportunistic infection, indications for biopsy, and acceptable approaches to immunosuppression, management of rejection, and antiretroviral therapy.
Results: Between November 2003 and June 2009, a total of 150 patients underwent kidney transplantation; survivors were followed for a median period of 1.7 years. Patient survival rates (±SD) at 1 year and 3 years were 94.6±2.0% and 88.2±3.8%, respectively, and the corresponding mean graft-survival rates were 90.4% and 73.7%. In general, these rates fall somewhere between those reported in the national database for older kidney-transplant recipients (≥65 years) and those reported for all kidney-transplant recipients. A multivariate proportional-hazards analysis showed that the risk of graft loss was increased among patients treated for rejection (hazard ratio, 2.8; 95% confidence interval [CI], 1.2 to 6.6; P=0.02) and those receiving antithymocyte globulin induction therapy (hazard ratio, 2.5; 95% CI, 1.1 to 5.6; P=0.03); living-donor transplants were protective (hazard ratio, 0.2; 95% CI, 0.04 to 0.8; P=0.02). A higher-than-expected rejection rate was observed, with 1-year and 3-year estimates of 31% (95% CI, 24 to 40) and 41% (95% CI, 32 to 52), respectively. HIV infection remained well controlled, with stable CD4+ T-cell counts and few HIV-associated complications.
Conclusions: In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection. The unexpectedly high rejection rates are of serious concern and indicate the need for better immunotherapy. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00074386.).
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3028983/bin/nihms253768f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3028983/bin/nihms253768f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3028983/bin/nihms253768f3.gif)
Comment in
-
Tackling the unknowns in HIV-related kidney diseases.N Engl J Med. 2010 Nov 18;363(21):2058-9. doi: 10.1056/NEJMe1010940. N Engl J Med. 2010. PMID: 21083392 No abstract available.
-
Outcomes of kidney transplantation in HIV-infected recipients.N Engl J Med. 2011 Feb 17;364(7):683; author reply 684. doi: 10.1056/NEJMc1014114. N Engl J Med. 2011. PMID: 21323551 No abstract available.
-
Outcomes of kidney transplantation in HIV-infected recipients.N Engl J Med. 2011 Feb 17;364(7):683; author reply 684. doi: 10.1056/NEJMc1014114. N Engl J Med. 2011. PMID: 21323552 No abstract available.
-
Transplantation: HIV infection is no barrier to kidney transplantation.Nat Rev Nephrol. 2011 Feb;7(2):63. doi: 10.1038/nrneph.2010.182. Nat Rev Nephrol. 2011. PMID: 21355121 No abstract available.
-
Kidney transplantation in HIV-infected patients.Am J Kidney Dis. 2011 Jul;58(1):10-2. doi: 10.1053/j.ajkd.2011.03.012. Epub 2011 Apr 29. Am J Kidney Dis. 2011. PMID: 21530034 No abstract available.
Similar articles
-
Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.Transpl Infect Dis. 2016 Oct;18(5):730-740. doi: 10.1111/tid.12592. Epub 2016 Sep 26. Transpl Infect Dis. 2016. PMID: 27503081
-
Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.Am J Transplant. 2016 Aug;16(8):2368-76. doi: 10.1111/ajt.13840. Epub 2016 May 25. Am J Transplant. 2016. PMID: 27111897 Free PMC article.
-
Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1. Ont Health Technol Assess Ser. 2010. PMID: 23074407 Free PMC article.
-
Solid organ transplants in HIV-infected patients.Curr HIV/AIDS Rep. 2013 Sep;10(3):217-25. doi: 10.1007/s11904-013-0170-z. Curr HIV/AIDS Rep. 2013. PMID: 23893004 Free PMC article. Review.
-
Kidney Transplantation in Patients with HIV.Kidney360. 2020 May 6;1(7):705-711. doi: 10.34067/KID.0002112020. eCollection 2020 Jul 30. Kidney360. 2020. PMID: 35372947 Free PMC article. Review.
Cited by
-
Cardiac and Renal Comorbidities in Aging People Living With HIV.Circ Res. 2024 May 24;134(11):1636-1660. doi: 10.1161/CIRCRESAHA.124.323948. Epub 2024 May 23. Circ Res. 2024. PMID: 38781295 Free PMC article. Review.
-
Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV.Clin Microbiol Rev. 2024 Mar 14;37(1):e0011122. doi: 10.1128/cmr.00111-22. Epub 2024 Jan 19. Clin Microbiol Rev. 2024. PMID: 38240603 Review.
-
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act.Transplantation. 2024 Mar 1;108(3):759-767. doi: 10.1097/TP.0000000000004857. Epub 2023 Nov 28. Transplantation. 2024. PMID: 38012862 Free PMC article.
-
Liver Transplantation in People Living with HIV: Still an Experimental Procedure or Standard of Care?Life (Basel). 2023 Sep 27;13(10):1975. doi: 10.3390/life13101975. Life (Basel). 2023. PMID: 37895356 Free PMC article. Review.
-
Management of Type 2 Diabetes Mellitus and Kidney Failure in People with HIV-Infection in Africa: Current Status and a Call to Action.HIV AIDS (Auckl). 2023 Sep 6;15:519-535. doi: 10.2147/HIV.S396949. eCollection 2023. HIV AIDS (Auckl). 2023. PMID: 37700755 Free PMC article. Review.
References
-
- Rao TK, Filippone EJ, Nicastri AD, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310:669��73. - PubMed
-
- Pardo V, Aldana M, Colton RM, et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med. 1984;101:429–34. - PubMed
-
- Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002;13:2997–3004. - PubMed
-
- Choi AI, Rodriguez RA, Bacchetti P, et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007;45:1633–9. - PubMed
-
- Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs. 2008;68:963–80. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials